Litcius/Paper detail

Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy

Lijun Wang, Jing Pan, Huanyu Meng, Zhao Yang, Lili Zeng, Jun Liu

2022Brain Sciences12 citationsDOIOpen Access PDF

Abstract

Patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) seropositive for autoantibodies against nodal and paranodal proteins display distinct clinical presentations. In the latest study, CIDP with autoantibodies against paranodal proteins was defined as autoimmune nodopathy (AN). We herein present a case of 39-year-old male with anti- neurofascin (NF) 155 and NF186 IgG4 antibody with gait disturbance and tremor, who was followed up for 4 months and demonstrated clinical improvements after apparently effective rituximab therapy. In addition, a literature review was conducted to investigate the clinical characteristics of anti-NF155/NF186-positive AN.

Topics & Concepts

AutoantibodyPolyradiculoneuropathyRituximabMedicineAntibodyImmunologyGuillain-Barre syndromePeripheral Neuropathies and DisordersHereditary Neurological DisordersMonoclonal and Polyclonal Antibodies Research
Anti-NF155/NF186 IgG4 Antibody Positive Autoimmune Nodopathy | Litcius